ID

30182

Description

CLL-Irl Study. ICORG 07-01, V7; ODM derived from: https://clinicaltrials.gov/show/NCT00812669

Lien

https://clinicaltrials.gov/show/NCT00812669

Mots-clés

Versions (1)
  1. 18/05/2018 18/05/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

18 mai 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Leukemia NCT00812669

Anglais

Eligibility Leukemia NCT00812669

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00812669
Criteria
Description

Criteria

diagnosis of chronic lymphocytic leukemia
Description

Chronic Lymphocytic Leukemia

Type de données

boolean

Alias
UMLS CUI [1]
C0023434
stage i-iv disease (binet stage progressive a, b, c)
Description

Progressive Disease Binet Staging System

Type de données

boolean

Alias
UMLS CUI [1,1]
C1335499
UMLS CUI [1,2]
C1511118
cd5 and cd23 positive
Description

Cell positive for CD5 antigen | Cell positive for CD23 antigen

Type de données

boolean

Alias
UMLS CUI [1]
C0882892
UMLS CUI [2]
C0945924
untreated or relapsed/resistant disease after combination chemotherapy or rituximab
Description

Disease untreated | Recurrent disease Post Combination Chemotherapy | Disease Resistant Post Combination Chemotherapy | Recurrent disease Post Rituximab | Disease Resistant Post Rituximab

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C0277556
UMLS CUI [2,2]
C0687676
UMLS CUI [2,3]
C1521750
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0332325
UMLS CUI [3,3]
C0687676
UMLS CUI [3,4]
C1521750
UMLS CUI [4,1]
C0277556
UMLS CUI [4,2]
C0687676
UMLS CUI [4,3]
C0393022
UMLS CUI [5,1]
C0012634
UMLS CUI [5,2]
C0332325
UMLS CUI [5,3]
C0687676
UMLS CUI [5,4]
C0393022
no 17p deletion
Description

Exclusion Loss of Chromosome 17p

Type de données

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C1517965
patient characteristics:
Description

Client Characteristics

Type de données

boolean

Alias
UMLS CUI [1]
C0815172
who performance status 0-2
Description

WHO performance status scale

Type de données

boolean

Alias
UMLS CUI [1]
C1298650
life expectancy > 1 year
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
creatinine clearance ≥ 50 ml/min
Description

Creatinine clearance measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0373595
hiv negative
Description

HIV negative

Type de données

boolean

Alias
UMLS CUI [1]
C0481430
not pregnant or nursing
Description

Pregnancy Absent | Breast Feeding Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
negative pregnancy test
Description

Pregnancy test negative

Type de données

boolean

Alias
UMLS CUI [1]
C0427780
fertile patients must use effective contraception
Description

Fertility Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no other concurrent malignancy except for noninvasive cervical cancer or localized nonmelanomatous skin cancer
Description

Exclusion Cancer Other | Exception Cervical cancer Noninvasive | Exception Skin carcinoma Localized

Type de données

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C4048328
UMLS CUI [2,3]
C2986496
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0699893
UMLS CUI [3,3]
C0392752
no history of anaphylaxis to mouse-derived humanized monoclonal antibody
Description

Exclusion Anaphylaxis Murine-Derived Monoclonal Antibodies Humanized

Type de données

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0002792
UMLS CUI [1,3]
C2916903
UMLS CUI [1,4]
C2985546
no other severe concurrent (e.g., cardiac or pulmonary) diseases or mental disorders that could interfere with ability to participate in the study
Description

Exclusion Criteria | Comorbidity Severe | Heart Diseases | Lung diseases | Mental disorders Interfere with Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0018799
UMLS CUI [4]
C0024115
UMLS CUI [5,1]
C0004936
UMLS CUI [5,2]
C0521102
UMLS CUI [5,3]
C2348568
prior concurrent therapy:
Description

Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Description

ID.18

Type de données

boolean

Retour au début de la page

Similar models

Eligibility Leukemia NCT00812669

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00812669
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Chronic Lymphocytic Leukemia
Item
diagnosis of chronic lymphocytic leukemia
boolean
C0023434 (UMLS CUI [1])
Progressive Disease Binet Staging System
Item
stage i-iv disease (binet stage progressive a, b, c)
boolean
C1335499 (UMLS CUI [1,1])
C1511118 (UMLS CUI [1,2])
Cell positive for CD5 antigen | Cell positive for CD23 antigen
Item
cd5 and cd23 positive
boolean
C0882892 (UMLS CUI [1])
C0945924 (UMLS CUI [2])
Disease untreated | Recurrent disease Post Combination Chemotherapy | Disease Resistant Post Combination Chemotherapy | Recurrent disease Post Rituximab | Disease Resistant Post Rituximab
Item
untreated or relapsed/resistant disease after combination chemotherapy or rituximab
boolean
C0012634 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0277556 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C1521750 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C0332325 (UMLS CUI [3,2])
C0687676 (UMLS CUI [3,3])
C1521750 (UMLS CUI [3,4])
C0277556 (UMLS CUI [4,1])
C0687676 (UMLS CUI [4,2])
C0393022 (UMLS CUI [4,3])
C0012634 (UMLS CUI [5,1])
C0332325 (UMLS CUI [5,2])
C0687676 (UMLS CUI [5,3])
C0393022 (UMLS CUI [5,4])
Exclusion Loss of Chromosome 17p
Item
no 17p deletion
boolean
C2828389 (UMLS CUI [1,1])
C1517965 (UMLS CUI [1,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
WHO performance status scale
Item
who performance status 0-2
boolean
C1298650 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 1 year
boolean
C0023671 (UMLS CUI [1])
Creatinine clearance measurement
Item
creatinine clearance ≥ 50 ml/min
boolean
C0373595 (UMLS CUI [1])
HIV negative
Item
hiv negative
boolean
C0481430 (UMLS CUI [1])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Exclusion Cancer Other | Exception Cervical cancer Noninvasive | Exception Skin carcinoma Localized
Item
no other concurrent malignancy except for noninvasive cervical cancer or localized nonmelanomatous skin cancer
boolean
C2828389 (UMLS CUI [1,1])
C1707251 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C4048328 (UMLS CUI [2,2])
C2986496 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
C0392752 (UMLS CUI [3,3])
Exclusion Anaphylaxis Murine-Derived Monoclonal Antibodies Humanized
Item
no history of anaphylaxis to mouse-derived humanized monoclonal antibody
boolean
C2828389 (UMLS CUI [1,1])
C0002792 (UMLS CUI [1,2])
C2916903 (UMLS CUI [1,3])
C2985546 (UMLS CUI [1,4])
Exclusion Criteria | Comorbidity Severe | Heart Diseases | Lung diseases | Mental disorders Interfere with Study Subject Participation Status
Item
no other severe concurrent (e.g., cardiac or pulmonary) diseases or mental disorders that could interfere with ability to participate in the study
boolean
C0680251 (UMLS CUI [1])
C0009488 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0018799 (UMLS CUI [3])
C0024115 (UMLS CUI [4])
C0004936 (UMLS CUI [5,1])
C0521102 (UMLS CUI [5,2])
C2348568 (UMLS CUI [5,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.18
Item
see disease characteristics
boolean
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial